NATIONAL \u2014 Popular weight loss drugs could soon be available at a Costco near you \u2014 and possibly for less.<\/p>\n
Novo Nordisk is partnering with the big-box retailer to offer Ozempic and Wegovy in Costco pharmacies starting Friday.<\/p>\n
Both Ozempic and Wegovy are GLP-1 prescription injectables used to manage Type 2 diabetes. They are also widely prescribed for weight loss and weight management.<\/p>\n
The medications will be available to Costco members without insurance for an out-of-pocket cost of $499, according to a Novo Nordisk spokesperson.<\/p>\n
However, the discounted pricing will only be available to members enrolled in the Costco Member Prescription Program.<\/p>\n
This move is part of Novo Nordisk\u2019s broader effort to expand access to its injectables in the U.S. by making them more affordable.<\/p>\n
\u201cEveryone deserves care that\u2019s simple, reliable, and within reach \u2014 and we\u2019re proud to lead the way in helping make that a reality,\u201d said Dave Moore, Executive Vice President of U.S. Operations at Novo Nordisk.<\/p>\n
Novo Nordisk has made similar agreements with other retail pharmacies.<\/p>\n
\u00a92025 Cox Media Group<\/p>\n","protected":false},"excerpt":{"rendered":"NATIONAL \u2014 Popular weight loss drugs could soon be available at a Costco near you \u2014 and possibly…\n","protected":false},"author":3,"featured_media":276794,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[64,9412,427,67,132,68,2402],"class_list":{"0":"post-276793","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-business","8":"tag-business","9":"tag-novo-nordisk","10":"tag-ozempic","11":"tag-united-states","12":"tag-unitedstates","13":"tag-us","14":"tag-wegovy"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/115315189060818490","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/276793","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=276793"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/276793\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/276794"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=276793"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=276793"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=276793"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}